































in anintensive care unit，however there arefew experiment uslng Cells regarding  
PrOteCtive e鮎cts oft，he combination ofpropofo1and dexmedetomidine．Meanwhile，  
intraoperativebrainischemia．reperfusioninducesendoplasmicreticulum（ER）－StreSS  
mediatedapoptosis．Theaimofourpresentstudyistoclarifymoleculardetai1softhe  




Pretreated with propofolor dexmedetomidine，Or the combination ofpropofbland  
dexmedetomidineforlhour befbre co－treatment With TGfor20hours．TG・induced  
apoptoticcellssigni丘cantlyincreased［Ca2＋］i，CaSPaSeaCtivations，andtheexpressionsof  
ER－StreSSbiomarkers，Theincreasein［Ca2＋］iandtheinductionofER・StreSSbyTGwere  
Suppl・eSSedbypretreatmentwithpropofolordexmedetomidine orthecombinationof  
PrOPO丘）1anddexmedetomidine．ThereductionofcaspaseactivitiesandtheER・StreSS  
biomarkerswithdexmedetomidinewereinhibitedbypretreatmentwithα2inhibitor．  
These suppressive e鮎ctsofdexmedetomidine werepromoted bypretreatmentwith  
CAMPinhibitor．Treatment with the combination ofpropofo1and dexmedetomidine  
＄howedthestrongestprotectionagalnStTG・inducedapoptosis．  
TlleSereSultsdemonstratethatthecombinationofpropofo1anddexmedetomidineat  
Clinically relevant concentration suppressed the ER－StreSSinduced apoptosisin  
neuroblastoma SH－SY5Yce11s．Itis suggestedthatthe combination ofpropofoland  
dexmedetomidinewithinclinicallyrelevantconcentrationmaybeusedsafelyinpatients．  
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thapslgarglm   
Int，rOduction  
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in Adult PatientsinIntensive Care Unit，nOnbenzodiazeplne・based sedation and  









Of propofo1were reported hypotension，bradycardia，reSPlratOry depression，and  
hypertriglyceridemia．Furthermore，itisknownprolonged use ofhighdose propofo1  
causespropofo1infusionsyndrome（PRIS），SOPrOlongeduseofhighdosepropofolshould  
beavoided2）．  





Sedative and analgesic properties and devoid of respiratory depressant e鮎ct5）．  
Dexmedetomidine presents an alternative to the GABA agonistsforICU sedation  
therapy．In addition to sedation，dexmedetomidine reduces concurrent analgesic  
requirements while maintaining patient’s arousability without compromising  
respiratory drive6）．Propofo1and dexmedetomidine haveless agitation and delirium  
COmParedwithbenzodiazeplne，SOthecombinationofpropofo1anddexmedetomidineis  
usedforsedationintheICUtokeepspontaneollSreSPirationandadequatesedativelevel．  
Severalstudies have reported that dexmedetomidineinfusion significantly spal・eS  
PrOPOfolreq111rementSduringtheinductionandthemaintenanceofgeneralanesthesia7）．  
Therearemanyl・epOrtSthatpropofo1hasneuroprotectiveeffbctsagainsttl・aumaand  
ischemic conditions8・9）．We previouslyl・ePOl・ted pl・OPOfolhas neuropl・OteCtive e鮎cts  
against ER・StreSS mediated apoptosislO）．Besides dexmedetomidineis well・prOVen  
Sedativee鮎ct＄，eVidencewasindicatedthatdexmedetomidineexertsacell－prOteCtive  
effbctonnel・VOuStissueunderischemicconditionll）．Recently，thecombinationofpropofo1  










The aim of our present studyis to clari＆ molecular details of the  
neuroprotectionwith the combination ofpropofo1and dexmedetomidine againstthe  
thapsigargin（TG）－inducedER－StreSSinSH－SY5Ycells，andwhetherthecombination  
assuredmoreefBcientnellrOprOteCtion．   
MaterialandMethods  
〃J叫ト．・川l／J＝ざ川Jメ  
Propofo1  （2，6．diisopropylphenol），  dexmedetomidine （5・［（1S）・1・（2，3・  
dimethylphenyl）ethyl］・1H－imidazole，hydrochloride），TG，and Dulbecco’s modified  
Eagle’smedium（DMEMHam’sF－12）werepurchasedfromWakoCo，（Osaka，Japan）．  
Fetalbovine serum（FBS），atipamezole and2’，5’一dideoxyadenosine（ddAdo）were  
purchased丘omSigma－AldrichCo．（MO，USA）．Antibiotic・antimycotic（PenicillinG、  
Streptomycin，AmphotericinB）wereobtained魚・Omlifeteclm0logy（USA，CA）．  
Allother chemicals usedin this experiment were the purest grade commercial1y  
available．  
（■lイ／ぐ〃／川代・．・川・古山町JルノIJ仙・〟／  






and cellsinduced apoptosis after prolonged exposure．Furthermore，We preViously  
reportedthatER・StreSSWaSinducedbylpMTGtreatmentinSH・SY5YcellslO）．Cells  
werepretreatedwithpropo丘〉1（1，5，10pM）ordexmedetomidine（1，10，100，1000nM）ol・  







Activities of caspase・3 and・4wel・e determined nuol・Ometrically with respective  
Syntheticpeptidesubstrates．  
SH・SY5Y cells wereincubated with pretreated with propofo1（1，5，10pM）or  
dexmedetomidine（1，10，100，1000nM）orthe combinationofprop＋dexforlhour  
fbllowedbytreatmentwithTGfor20・hours．Afterincubation，thecellswererinsedwith  
coldPBSandre・SuSPendedinchilledcelllysisbuffbr（CellsignalingTbchnologyInc．，MA，  




caspase・4（BioVision TbchnologyInc．，叩，USA）wereAsp－Glu－Ⅵ1l－Asp－7－amino－4－  









With a cold cel11ysis bu鮎r and sonicated with an ultrasonic celldisruptel・．For  
quantitative determination ofCHOPin SH－SY5Ycellslysates，ELISAkitfor DNA  
damageinducibletranscript3（CHOP）（UscnLifeScienceInc．Wuhan，China）wereused．  
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hourfo1lowed by treatment with TGfor20・hours．Aftel・SH・SY5Y cells were pre．  
incubated with atipame2．01e，forlO・minutes before treatment with pl・OPOfolor  
dexmedetomidine，meaSurement Of cyclic AMP was underwentin accordance with  
protocol．   
／〃〃1・いイ／扇げ／hで－：・J・小：・∫、／リノ…川ハ・仙州．ヾ／ミl∴lノー山．＼ナりいJ．りJ情甘．・．・1り－Jふ加・′J  
Levelsof［Ca2＋】iwereanalyzedusingaFLIPRCalcium5AssayKit（MolecularDevices，  
Inc．，CA，USA）．SH．SY5YcellswereloadedwithFLIPRreagentdilutedin Hank，s  
balancedsaltsolution＋20mMHepesbu鮎r（pH7A）forl・hourat370C．  
AfEerSH－SY5YcellswereincubatedwitllFLIPRreagent，Changesinthe【Ca2十］iWere  






with thosein the untreated controIcells was performed with one・WayANOVAand  
I）unnett’sastheposthoctest．Differenceswithp・ValuesoflessthanO．05wereconsidered  





In SH－SY5Ycells，neither treatmentwithpropofo1（1，5LLM）nor treatment with  








This showed thatpropofo1or dexmedetomidineinhibited apoptosisinduced by TG．  
However，Pretreatment With dexmedetomidine at high concentration promoted ER  
StreSS－inducedapoptosis．  
I）exmedetomidine■s e脆cts can beinhibited by the high1y specific（12－adrenocepter  
antagonistatipamezole14）．Whenatipamezolewasincubatedbe氏〉reCO－treatmentwith  
dexmedetomidine（10nM）and TG，the caspase．3activity significantlyincreased  
comparedwithTG＋dex（10nM）treatedcells（Fig．1．B），Thisresearchsupportedthat  

























Fig．4．shows the phosphorylation of eIF2cLin SH．SY5Y cells．The eIF2cIShowed  
SignificantlylnCreaSedphosphorylationin TG．treated cells，Which was slgni丘cantly  
SuPpreSSed bypropofolor dexmedetomidine orcombination ofprop＋dex．UnderTG．  
inducedER＄treSS，treatmentWiththecombinationofprop＋dex（10nM）signi丘cantly  






I）exmedetomidine binds to the α2・adrenoceptor thatis coupled through the Gi  
mechanismandinhibitsadenylylcyclaseactivityanddownregulatescAMPhrmation15）．  
In thefo1lowlng eXPeriments，Weinvestigated whether the cAMPisinvoIvedinthe  















the release of Ca2＋ 丘om the ERinduced by TGlO）． Pretreatment with  
dexmedetomidine（10nM）signi且cantly suppressedcAMPlevelsinTG・inducedER  
StreSS Ofcells（Fig・5）・Pre・incubationwith membrane－Permeable adenylylcyclase  
inhibitorddAdo（100pM）showedthefurthersuppressionof［Ca2・】ilevelscompared  
With co・treatedwithdexmedetomidineandTG，Therefore，therepressionofthe［Ca2＋］i  
levelbydexmedetomidinehasbeenshowntomediateadecreaseinthecellularcAMP  
levels．  
10   
Discussion  
In this study，We Showed that the combination ofpropofbland dexmedetomidine  
SuPPl・eSSedER・Stl・eSSmediatedapoptosisinSH．SY5Ycells．WhenSH・SY5Ycellswere  
treated with the combination ofprop＋dex，ER＄treSS－mediated apoptosis was more  
SupPreSSed compared to treatment with propofolor dexmedetomidine，reSPeCtively．  
Especially，COmbinationoflトLMpropofo1andlOnMdexmedetomidinehadthestrongest  
neuroprotectivee脆cts．   
Typically，Patientsreceivel－2，5mg／kgpropofo1asanintravenousbolusinJeCtionfor  
theinductionofgeneralanesthesia．Whenweusetargetcontrolinfusion（TCI）pump，  







concentration of O．22・2．50 ng／ml（1．1・12，5 nM），Furthermore，the plasma  










to theinvasiveincidents．However，uPOn eXCeSSively severeinvasiveincidents，Cells  
CannOtbeadaptedandapoptosisisinducedviaER－StreSS．  





reseArchers treated the human glioblastoma cells with300．500pM propofo1and  
observedtheincreasein［Ca2＋］iandtheyreportedpropofblpromotedapoptosisindose－  




Clinically relevant concentration showed neuroprotective e晩cts，Propofo1protects  
nerve，Pulmonary epithelial，VaSCular endothellaland kidney cells20－22）．We have  
previouslyreportedthatpropofo1（5pM）suppressedtheER・StreSS・inducedapoptosis  
byinhibitionoftheCa2＋release丘omER10）．  
Dexmedetomidineis a potent and highly selective a酢）nist of the（12・  
a，drenoceptorsonthehumanbrain，includingclinicalsedation，aneSthetic－SParlngeffbcts，  
and analgesia23）．Recent studyindicated that dexmedetomidine also exhibits  
neuroprotectionagalnStischemiclnJury24）andpromotessurvivalofnervoustissuethat  
has suffered traumaticinJury25）．However，a Studyin neutrophils has shown that  





decreased the TG－Stimulated［Ca2＋】ielevation，Pre・incubation with membrane・  















is，PrOPOfo1inhibits the Ca2＋release＆omERlO），and dexmedetomidine binds to cL2－  
adrenoceptorsandthendecreasestheintracellularcAMPlevels．  
12   
DexmedetomidinehasimidazolederivativestruCtura11yandbindstonotonly  











We havefound thatthe combinationofpropofo1anddexmedetomidine hasa strong  
PrOteCtive effect on ER－StreSS mediated apoptosisin SH－SY5Y cells． The  
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16   
Figure Legends 









ERstress．Eachvaluerepresentsthemeanj＝S．E．M．ofll－59samples．   
a：statisticaldifferencecalculatedversusIpMTG・treatedcells（p＜0，05）   
b：statisticaldi脆rence calculated vers11SlpM TG＋1pM propofo1treated cells   
b＜0．05）   
C：statisticaldifference calculated versuslpM TG＋1000nM dexmedetomidine   
treatedcells（p＜0．05）   
d：statisticaldi脆rencecalculatedversuslpMTG＋10nMdexmedetomidinetreated   

















17   
CHOPlevelwas examined11Sing ELISA kit．The e鮎ct of propofo1（1pM）and  
dexmedetomidine（1，10，100nM）oncHOPlevelinTG－treatedapoptoticSH－SY5Ycells  


















CAMPlevelwas examined using ELISAldt．The effect of propofo1（1pM）and  
dexmedetomidine（1，10，100nM）oncAMPlevelinTG・treatedapoptoticSH－SY5Ycells  











18   
nM）wel・emeaSured．  
仏）Photographs showalterationsin［Ca2＋］ilevel＄in SH－SY5Ycells．White ofthe   
brightnessareashowslligh［Ca2＋］ilevelsinSH－SY5Y  
（B）Eachvaluerepresentsthemeanj＝S．e．m．Of30plates．Valuesareexpressedas   
PerCentageSinfluorescenceintensitybeforetreatment．   
☆：statisticaldiffbrencecalculatedversuslpMpropofbl，10nMdexmedetomidine  
orProp＋dex－treatedcells（p＜0．05）．  
＃：statisticaldi飴rence calculated versuslllM TG＋10nM dexmedetomidine  
treatedcells（p＜0．05）  
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